Krugman Insights | Premier Financial Intelligence & Deal Tracking
Barclays, J.P.Morgan, Wells Fargo, and BNP Paribas Exclusive: Lead Historic $13.5 Billion Acquisition of Schroders as EMEA FIG M&A Accelerates
Advised by Barclays, J.P. Morgan, Wells Fargo, and BNP Paribas, the US asset management giant Nuveen has engineered a landmark $13.5 Billion transatlantic merger with Schroders. This deal marks the most aggressive move yet by an American firm to capture a heritage British institution, signalling a strategic surrender to the reality that in the modern era of asset management, scale is the only viable defense against the relentless march of passive investing.
Today's Most Read
Morgan Stanley and Centerview Partners: Lead Record-Breaking $7.8 Billion Gilead Acquisition
Most Popular
Rankings
The 2025 Global Small-Cap M&A Rankings: The Big Four’s Consolidation of the Liquidity Gap
The 2026 Emerging Markets M&A Rankings: Wall Street Consolidates the Globe as National Champions Guard the Gates
M&A
Morgan Stanley and Centerview Partners: Lead Record-Breaking $7.8 Billion Gilead Acquisition
Researcher's Note: This is one of the most exciting deals we've seen in healthcare in a long time and especially in 2026. As is always the case with...
Lazard, Barclays and J.P. Morgan Exclusive: Lead Historic $1.9 Billion Portland General Electric Acquisition in Energy M&A Deal of the Week
J.P. Morgan, Bank of America, and Moelis Exclusive: Lead Record-Breaking $1.7bn Kennedy Wilson Acquisition as February M&A Accelerates
Macquarie and UBS Exclusive: Architect Record-Breaking $11.7 Billion Privatisation of Qube as APAC Leads 2026 M&A Boom
Private Equity
BlackRock Exclusive: Record-Breaking $240 Million Investment in Philippine's Infrastructure as Private Equity Chases Asia
Featured Analysis
Morgan Stanley and Centerview Partners: Lead Record-Breaking $7.8 Billion Gilead Acquisition
What You Need To Know:
Morgan Stanley and Centerview Partners have started off the week by engineering Krugman Research's Most Exciting Healthcare Deal of the Month' through Gilead Sciences’ decisive $7.8 billion takeover of its biotech partner Arcellx. This transaction abruptly terminates a previous profit-sharing agreement in favor of absolute ownership, proving that Gilead is willing to deploy a massive 68% premium to monopolize the economics of a revolutionary synthetic cancer therapy just months before its highly anticipated commercial launch.
Morgan Stanley and Centerview Partners: Lead Record-Breaking $7.8 Billion Gilead Acquisition
Morgan Stanley and Centerview Partners have started off the week by engineering Krugman Research's Most Exciting Healthcare Deal of the Month' through Gilead Sciences’ decisive $7.8 billion takeover of its biotech partner Arcellx. This transaction abruptly terminates a previous profit-sharing agreement in favor of absolute ownership, proving that Gilead is willing to deploy a massive 68% premium to monopolize the economics of a revolutionary synthetic cancer therapy just months before its highly anticipated commercial launch.
Live Deal Intelligence
Track deal flow and market intelligence from prestigious financial institutions.
Elite M&A Intelligence
Popular Sectors
TMT
J.P. Morgan, Qatalyst Partners, and Wells Fargo Exclusive: Architect Landmark $3 Billion SiTime Acquisition as AI M&A Accelerates
Deutsche Bank and Goldman Sachs Exclusive: Engineer Record-Breaking $1.2 Billion Acquisition of Legend as 2026 TMT M&A Rallies
Perella Weinberg and J.P. Morgan Exclusive: Engineer WTW’s Record $1.3 Billion Acquisition in Latest FIG M&A Rally
Lazard, Peel Hunt and Investec Exclusive: Lead Record £275 Million NCC Restructuring as Europe’s TMT Sector Heats Up
Healthcare
Morgan Stanley and Centerview Partners: Lead Record-Breaking $7.8 Billion Gilead Acquisition
J.P.Morgan and Evercore Exclusive: Lead Historic $2.2 Billion GSK Acquisition as Healthcare M&A Continues Strong Recovery
Perella Weinberg Exclusive: Engineers Record-Breaking $14.5bn Boston Scientific Acquisition as Healthcare M&A Hits Record
Jefferies, Bank of America and Moelis: Engineer Historic $1.2 Billion Eli Lilly Acquisition as Global Healthcare Race Accelerates
Energy
BlackRock Exclusive: Record-Breaking $40bn Data Centre Acquisition Dampens AI Bubble Fears
CVC Exclusive: New £1.1bn Takeover of Low Carbon to Supercharge the European Energy Transition
Morgan Stanley, Santander Exclusive: Advise National Grid on £1.6bn Grain LNG Exit as Energy M&A Heats Up
BlackRock Exclusive: New $70bn Middle East Expansion Strategy as Infrastructure and AI Drive Demand
Trending Now
How Credit Sets the Buyout Cycle
Private equity runs on leverage. Its buyout activity doesn’t move in straight lines, instead due to market factors, it...